Recent Analyst Forecasts and Stock Ratings
Design Therapeutics, Inc. FAQ's
Design Therapeutics, Inc. has been rated by research analysts at Craig-Hallum, Leerink Partners, Piper Sandler, RBC Capital, Goldman Sachs in the past 90 days.
Design Therapeutics, Inc. has been rated by research analysts at Craig-Hallum, Leerink Partners, Piper Sandler, RBC Capital, Goldman Sachs in the past 90 days.